nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Imiquimod—skin cancer	0.151	0.292	CbGbCtD
Etonogestrel—CYP3A4—Temozolomide—skin cancer	0.151	0.292	CbGbCtD
Etonogestrel—CYP3A4—Vismodegib—skin cancer	0.105	0.202	CbGbCtD
Etonogestrel—CYP3A4—Vemurafenib—skin cancer	0.0827	0.16	CbGbCtD
Etonogestrel—CYP3A4—Docetaxel—skin cancer	0.0284	0.0548	CbGbCtD
Etonogestrel—SHBG—hindlimb—skin cancer	0.0117	0.205	CbGeAlD
Etonogestrel—PGR—blood vessel—skin cancer	0.00503	0.0883	CbGeAlD
Etonogestrel—SHBG—neck—skin cancer	0.004	0.0702	CbGeAlD
Etonogestrel—ESR1—blood vessel—skin cancer	0.00394	0.0691	CbGeAlD
Etonogestrel—PGR—nipple—skin cancer	0.00364	0.0639	CbGeAlD
Etonogestrel—SHBG—connective tissue—skin cancer	0.00286	0.0503	CbGeAlD
Etonogestrel—ESR1—neck—skin cancer	0.00282	0.0494	CbGeAlD
Etonogestrel—PGR—connective tissue—skin cancer	0.00258	0.0453	CbGeAlD
Etonogestrel—PGR—epithelium—skin cancer	0.00245	0.043	CbGeAlD
Etonogestrel—SHBG—female reproductive system—skin cancer	0.00202	0.0355	CbGeAlD
Etonogestrel—ESR1—connective tissue—skin cancer	0.00202	0.0354	CbGeAlD
Etonogestrel—ESR1—epithelium—skin cancer	0.00192	0.0336	CbGeAlD
Etonogestrel—PGR—lymphoid tissue—skin cancer	0.00189	0.0331	CbGeAlD
Etonogestrel—PGR—female reproductive system—skin cancer	0.00182	0.0319	CbGeAlD
Etonogestrel—PGR—head—skin cancer	0.00152	0.0267	CbGeAlD
Etonogestrel—ESR1—lymphoid tissue—skin cancer	0.00148	0.0259	CbGeAlD
Etonogestrel—ESR1—female reproductive system—skin cancer	0.00142	0.025	CbGeAlD
Etonogestrel—ESR1—head—skin cancer	0.00119	0.0209	CbGeAlD
Etonogestrel—PGR—lymph node—skin cancer	0.00106	0.0187	CbGeAlD
Etonogestrel—ESR1—lymph node—skin cancer	0.000833	0.0146	CbGeAlD
Etonogestrel—CYP3A4—female reproductive system—skin cancer	0.000794	0.0139	CbGeAlD
Etonogestrel—Swelling—Docetaxel—skin cancer	0.000752	0.00177	CcSEcCtD
Etonogestrel—Urinary tract infection—Temozolomide—skin cancer	0.000747	0.00176	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000745	0.00175	CcSEcCtD
Etonogestrel—Insomnia—Imiquimod—skin cancer	0.00074	0.00174	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000738	0.00173	CcSEcCtD
Etonogestrel—Paraesthesia—Imiquimod—skin cancer	0.000735	0.00173	CcSEcCtD
Etonogestrel—Somnolence—Imiquimod—skin cancer	0.000727	0.00171	CcSEcCtD
Etonogestrel—Alopecia—Bleomycin—skin cancer	0.000723	0.0017	CcSEcCtD
Etonogestrel—Sinusitis—Temozolomide—skin cancer	0.000721	0.00169	CcSEcCtD
Etonogestrel—Dyspepsia—Imiquimod—skin cancer	0.00072	0.00169	CcSEcCtD
Etonogestrel—Erythema—Bleomycin—skin cancer	0.000712	0.00167	CcSEcCtD
Etonogestrel—Decreased appetite—Imiquimod—skin cancer	0.000711	0.00167	CcSEcCtD
Etonogestrel—Hot flush—Docetaxel—skin cancer	0.000709	0.00167	CcSEcCtD
Etonogestrel—Infestation—Fluorouracil—skin cancer	0.000708	0.00166	CcSEcCtD
Etonogestrel—Infestation NOS—Fluorouracil—skin cancer	0.000708	0.00166	CcSEcCtD
Etonogestrel—Hypersensitivity—Vemurafenib—skin cancer	0.000707	0.00166	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Imiquimod—skin cancer	0.000706	0.00166	CcSEcCtD
Etonogestrel—Fatigue—Imiquimod—skin cancer	0.000705	0.00166	CcSEcCtD
Etonogestrel—Menopausal symptoms—Docetaxel—skin cancer	0.000703	0.00165	CcSEcCtD
Etonogestrel—Visual disturbance—Docetaxel—skin cancer	0.0007	0.00164	CcSEcCtD
Etonogestrel—Pain—Imiquimod—skin cancer	0.0007	0.00164	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Fluorouracil—skin cancer	0.000694	0.00163	CcSEcCtD
Etonogestrel—Haemoglobin—Temozolomide—skin cancer	0.000694	0.00163	CcSEcCtD
Etonogestrel—Haemorrhage—Temozolomide—skin cancer	0.00069	0.00162	CcSEcCtD
Etonogestrel—Urinary tract infection—Fluorouracil—skin cancer	0.000688	0.00162	CcSEcCtD
Etonogestrel—Asthenia—Vemurafenib—skin cancer	0.000688	0.00162	CcSEcCtD
Etonogestrel—Hypoaesthesia—Temozolomide—skin cancer	0.000687	0.00161	CcSEcCtD
Etonogestrel—Pharyngitis—Temozolomide—skin cancer	0.000685	0.00161	CcSEcCtD
Etonogestrel—Urinary tract disorder—Temozolomide—skin cancer	0.000681	0.0016	CcSEcCtD
Etonogestrel—Pruritus—Vemurafenib—skin cancer	0.000679	0.00159	CcSEcCtD
Etonogestrel—Connective tissue disorder—Temozolomide—skin cancer	0.000678	0.00159	CcSEcCtD
Etonogestrel—Urethral disorder—Temozolomide—skin cancer	0.000676	0.00159	CcSEcCtD
Etonogestrel—Alopecia—Dactinomycin—skin cancer	0.000674	0.00158	CcSEcCtD
Etonogestrel—Feeling abnormal—Imiquimod—skin cancer	0.000674	0.00158	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Imiquimod—skin cancer	0.000669	0.00157	CcSEcCtD
Etonogestrel—Visual impairment—Temozolomide—skin cancer	0.000665	0.00156	CcSEcCtD
Etonogestrel—Sinusitis—Fluorouracil—skin cancer	0.000664	0.00156	CcSEcCtD
Etonogestrel—Erythema—Dactinomycin—skin cancer	0.000664	0.00156	CcSEcCtD
Etonogestrel—Pain in extremity—Docetaxel—skin cancer	0.000663	0.00156	CcSEcCtD
Etonogestrel—Ill-defined disorder—Bleomycin—skin cancer	0.000661	0.00155	CcSEcCtD
Etonogestrel—Diarrhoea—Vemurafenib—skin cancer	0.000656	0.00154	CcSEcCtD
Etonogestrel—Migraine—Docetaxel—skin cancer	0.000653	0.00153	CcSEcCtD
Etonogestrel—Urticaria—Imiquimod—skin cancer	0.00065	0.00153	CcSEcCtD
Etonogestrel—Abdominal pain—Imiquimod—skin cancer	0.000647	0.00152	CcSEcCtD
Etonogestrel—Body temperature increased—Imiquimod—skin cancer	0.000647	0.00152	CcSEcCtD
Etonogestrel—Eye disorder—Temozolomide—skin cancer	0.000645	0.00152	CcSEcCtD
Etonogestrel—Malaise—Bleomycin—skin cancer	0.000642	0.00151	CcSEcCtD
Etonogestrel—Haemoglobin—Fluorouracil—skin cancer	0.000639	0.0015	CcSEcCtD
Etonogestrel—Rhinitis—Fluorouracil—skin cancer	0.000637	0.0015	CcSEcCtD
Etonogestrel—Haemorrhage—Fluorouracil—skin cancer	0.000636	0.00149	CcSEcCtD
Etonogestrel—Dizziness—Vemurafenib—skin cancer	0.000634	0.00149	CcSEcCtD
Etonogestrel—Hypoaesthesia—Fluorouracil—skin cancer	0.000633	0.00149	CcSEcCtD
Etonogestrel—Pharyngitis—Fluorouracil—skin cancer	0.000631	0.00148	CcSEcCtD
Etonogestrel—Angiopathy—Temozolomide—skin cancer	0.000626	0.00147	CcSEcCtD
Etonogestrel—Immune system disorder—Temozolomide—skin cancer	0.000623	0.00146	CcSEcCtD
Etonogestrel—Cough—Bleomycin—skin cancer	0.000621	0.00146	CcSEcCtD
Etonogestrel—Ill-defined disorder—Dactinomycin—skin cancer	0.000616	0.00145	CcSEcCtD
Etonogestrel—Vomiting—Vemurafenib—skin cancer	0.00061	0.00143	CcSEcCtD
Etonogestrel—Alopecia—Temozolomide—skin cancer	0.00061	0.00143	CcSEcCtD
Etonogestrel—Myalgia—Bleomycin—skin cancer	0.000606	0.00142	CcSEcCtD
Etonogestrel—Rash—Vemurafenib—skin cancer	0.000605	0.00142	CcSEcCtD
Etonogestrel—Mental disorder—Temozolomide—skin cancer	0.000605	0.00142	CcSEcCtD
Etonogestrel—Dermatitis—Vemurafenib—skin cancer	0.000604	0.00142	CcSEcCtD
Etonogestrel—Hypersensitivity—Imiquimod—skin cancer	0.000603	0.00142	CcSEcCtD
Etonogestrel—Headache—Vemurafenib—skin cancer	0.000601	0.00141	CcSEcCtD
Etonogestrel—Erythema—Temozolomide—skin cancer	0.000601	0.00141	CcSEcCtD
Etonogestrel—Malnutrition—Temozolomide—skin cancer	0.000601	0.00141	CcSEcCtD
Etonogestrel—Breast disorder—Docetaxel—skin cancer	0.000599	0.00141	CcSEcCtD
Etonogestrel—Discomfort—Bleomycin—skin cancer	0.000599	0.00141	CcSEcCtD
Etonogestrel—Malaise—Dactinomycin—skin cancer	0.000599	0.00141	CcSEcCtD
Etonogestrel—Cramp muscle—Docetaxel—skin cancer	0.000597	0.0014	CcSEcCtD
Etonogestrel—Asthenia—Imiquimod—skin cancer	0.000587	0.00138	CcSEcCtD
Etonogestrel—Oedema—Bleomycin—skin cancer	0.000581	0.00137	CcSEcCtD
Etonogestrel—Anaphylactic shock—Bleomycin—skin cancer	0.000581	0.00137	CcSEcCtD
Etonogestrel—Back pain—Temozolomide—skin cancer	0.000581	0.00137	CcSEcCtD
Etonogestrel—Pruritus—Imiquimod—skin cancer	0.000579	0.00136	CcSEcCtD
Etonogestrel—Infection—Bleomycin—skin cancer	0.000577	0.00136	CcSEcCtD
Etonogestrel—Nausea—Vemurafenib—skin cancer	0.00057	0.00134	CcSEcCtD
Etonogestrel—Myalgia—Dactinomycin—skin cancer	0.000565	0.00133	CcSEcCtD
Etonogestrel—Alopecia—Fluorouracil—skin cancer	0.000562	0.00132	CcSEcCtD
Etonogestrel—Diarrhoea—Imiquimod—skin cancer	0.00056	0.00132	CcSEcCtD
Etonogestrel—Discomfort—Dactinomycin—skin cancer	0.000559	0.00131	CcSEcCtD
Etonogestrel—Ill-defined disorder—Temozolomide—skin cancer	0.000557	0.00131	CcSEcCtD
Etonogestrel—Anorexia—Bleomycin—skin cancer	0.000554	0.0013	CcSEcCtD
Etonogestrel—Erythema—Fluorouracil—skin cancer	0.000553	0.0013	CcSEcCtD
Etonogestrel—Angioedema—Temozolomide—skin cancer	0.000549	0.00129	CcSEcCtD
Etonogestrel—Oedema—Dactinomycin—skin cancer	0.000542	0.00127	CcSEcCtD
Etonogestrel—Malaise—Temozolomide—skin cancer	0.000542	0.00127	CcSEcCtD
Etonogestrel—Dizziness—Imiquimod—skin cancer	0.000541	0.00127	CcSEcCtD
Etonogestrel—Infection—Dactinomycin—skin cancer	0.000539	0.00127	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00053	0.00124	CcSEcCtD
Etonogestrel—Cough—Temozolomide—skin cancer	0.000524	0.00123	CcSEcCtD
Etonogestrel—Paraesthesia—Bleomycin—skin cancer	0.000522	0.00123	CcSEcCtD
Etonogestrel—Weight increased—Docetaxel—skin cancer	0.000522	0.00123	CcSEcCtD
Etonogestrel—Convulsion—Temozolomide—skin cancer	0.00052	0.00122	CcSEcCtD
Etonogestrel—Vomiting—Imiquimod—skin cancer	0.00052	0.00122	CcSEcCtD
Etonogestrel—Weight decreased—Docetaxel—skin cancer	0.000519	0.00122	CcSEcCtD
Etonogestrel—Hypertension—Temozolomide—skin cancer	0.000519	0.00122	CcSEcCtD
Etonogestrel—Anorexia—Dactinomycin—skin cancer	0.000517	0.00121	CcSEcCtD
Etonogestrel—Rash—Imiquimod—skin cancer	0.000516	0.00121	CcSEcCtD
Etonogestrel—Dermatitis—Imiquimod—skin cancer	0.000515	0.00121	CcSEcCtD
Etonogestrel—Headache—Imiquimod—skin cancer	0.000513	0.0012	CcSEcCtD
Etonogestrel—Myalgia—Temozolomide—skin cancer	0.000511	0.0012	CcSEcCtD
Etonogestrel—Arthralgia—Temozolomide—skin cancer	0.000511	0.0012	CcSEcCtD
Etonogestrel—Infestation NOS—Docetaxel—skin cancer	0.000511	0.0012	CcSEcCtD
Etonogestrel—Infestation—Docetaxel—skin cancer	0.000511	0.0012	CcSEcCtD
Etonogestrel—Anxiety—Temozolomide—skin cancer	0.00051	0.0012	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000508	0.00119	CcSEcCtD
Etonogestrel—Discomfort—Temozolomide—skin cancer	0.000505	0.00119	CcSEcCtD
Etonogestrel—Decreased appetite—Bleomycin—skin cancer	0.000505	0.00119	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Docetaxel—skin cancer	0.000501	0.00118	CcSEcCtD
Etonogestrel—Pain—Bleomycin—skin cancer	0.000497	0.00117	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000494	0.00116	CcSEcCtD
Etonogestrel—Anaphylactic shock—Temozolomide—skin cancer	0.00049	0.00115	CcSEcCtD
Etonogestrel—Oedema—Temozolomide—skin cancer	0.00049	0.00115	CcSEcCtD
Etonogestrel—Infection—Temozolomide—skin cancer	0.000487	0.00114	CcSEcCtD
Etonogestrel—Nausea—Imiquimod—skin cancer	0.000486	0.00114	CcSEcCtD
Etonogestrel—Nervous system disorder—Temozolomide—skin cancer	0.000481	0.00113	CcSEcCtD
Etonogestrel—Convulsion—Fluorouracil—skin cancer	0.00048	0.00113	CcSEcCtD
Etonogestrel—Feeling abnormal—Bleomycin—skin cancer	0.000479	0.00113	CcSEcCtD
Etonogestrel—Skin disorder—Temozolomide—skin cancer	0.000476	0.00112	CcSEcCtD
Etonogestrel—Myalgia—Fluorouracil—skin cancer	0.000471	0.00111	CcSEcCtD
Etonogestrel—Decreased appetite—Dactinomycin—skin cancer	0.000471	0.00111	CcSEcCtD
Etonogestrel—Fatigue—Dactinomycin—skin cancer	0.000467	0.0011	CcSEcCtD
Etonogestrel—Anorexia—Temozolomide—skin cancer	0.000467	0.0011	CcSEcCtD
Etonogestrel—Discomfort—Fluorouracil—skin cancer	0.000466	0.00109	CcSEcCtD
Etonogestrel—Pain—Dactinomycin—skin cancer	0.000464	0.00109	CcSEcCtD
Etonogestrel—Urticaria—Bleomycin—skin cancer	0.000462	0.00108	CcSEcCtD
Etonogestrel—Haemoglobin—Docetaxel—skin cancer	0.000461	0.00108	CcSEcCtD
Etonogestrel—Rhinitis—Docetaxel—skin cancer	0.00046	0.00108	CcSEcCtD
Etonogestrel—Body temperature increased—Bleomycin—skin cancer	0.000459	0.00108	CcSEcCtD
Etonogestrel—Haemorrhage—Docetaxel—skin cancer	0.000459	0.00108	CcSEcCtD
Etonogestrel—Hypoaesthesia—Docetaxel—skin cancer	0.000457	0.00107	CcSEcCtD
Etonogestrel—Pharyngitis—Docetaxel—skin cancer	0.000455	0.00107	CcSEcCtD
Etonogestrel—Urinary tract disorder—Docetaxel—skin cancer	0.000453	0.00106	CcSEcCtD
Etonogestrel—Oedema—Fluorouracil—skin cancer	0.000452	0.00106	CcSEcCtD
Etonogestrel—Anaphylactic shock—Fluorouracil—skin cancer	0.000452	0.00106	CcSEcCtD
Etonogestrel—Connective tissue disorder—Docetaxel—skin cancer	0.000451	0.00106	CcSEcCtD
Etonogestrel—Urethral disorder—Docetaxel—skin cancer	0.00045	0.00106	CcSEcCtD
Etonogestrel—Infection—Fluorouracil—skin cancer	0.000449	0.00105	CcSEcCtD
Etonogestrel—Feeling abnormal—Dactinomycin—skin cancer	0.000447	0.00105	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000447	0.00105	CcSEcCtD
Etonogestrel—Insomnia—Temozolomide—skin cancer	0.000443	0.00104	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dactinomycin—skin cancer	0.000443	0.00104	CcSEcCtD
Etonogestrel—Nervous system disorder—Fluorouracil—skin cancer	0.000443	0.00104	CcSEcCtD
Etonogestrel—Visual impairment—Docetaxel—skin cancer	0.000442	0.00104	CcSEcCtD
Etonogestrel—Paraesthesia—Temozolomide—skin cancer	0.00044	0.00103	CcSEcCtD
Etonogestrel—Somnolence—Temozolomide—skin cancer	0.000436	0.00102	CcSEcCtD
Etonogestrel—Dyspepsia—Temozolomide—skin cancer	0.000432	0.00101	CcSEcCtD
Etonogestrel—Anorexia—Fluorouracil—skin cancer	0.000431	0.00101	CcSEcCtD
Etonogestrel—Eye disorder—Docetaxel—skin cancer	0.000429	0.00101	CcSEcCtD
Etonogestrel—Abdominal pain—Dactinomycin—skin cancer	0.000428	0.00101	CcSEcCtD
Etonogestrel—Body temperature increased—Dactinomycin—skin cancer	0.000428	0.00101	CcSEcCtD
Etonogestrel—Hypersensitivity—Bleomycin—skin cancer	0.000428	0.00101	CcSEcCtD
Etonogestrel—Decreased appetite—Temozolomide—skin cancer	0.000426	0.001	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Temozolomide—skin cancer	0.000423	0.000994	CcSEcCtD
Etonogestrel—Fatigue—Temozolomide—skin cancer	0.000423	0.000993	CcSEcCtD
Etonogestrel—Pain—Temozolomide—skin cancer	0.000419	0.000985	CcSEcCtD
Etonogestrel—Constipation—Temozolomide—skin cancer	0.000419	0.000985	CcSEcCtD
Etonogestrel—Asthenia—Bleomycin—skin cancer	0.000417	0.00098	CcSEcCtD
Etonogestrel—Angiopathy—Docetaxel—skin cancer	0.000416	0.000978	CcSEcCtD
Etonogestrel—Immune system disorder—Docetaxel—skin cancer	0.000415	0.000974	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000412	0.000967	CcSEcCtD
Etonogestrel—Pruritus—Bleomycin—skin cancer	0.000411	0.000966	CcSEcCtD
Etonogestrel—Insomnia—Fluorouracil—skin cancer	0.000409	0.00096	CcSEcCtD
Etonogestrel—Paraesthesia—Fluorouracil—skin cancer	0.000406	0.000953	CcSEcCtD
Etonogestrel—Alopecia—Docetaxel—skin cancer	0.000406	0.000953	CcSEcCtD
Etonogestrel—Feeling abnormal—Temozolomide—skin cancer	0.000404	0.000949	CcSEcCtD
Etonogestrel—Mental disorder—Docetaxel—skin cancer	0.000402	0.000945	CcSEcCtD
Etonogestrel—Somnolence—Fluorouracil—skin cancer	0.000402	0.000943	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Temozolomide—skin cancer	0.000401	0.000942	CcSEcCtD
Etonogestrel—Erythema—Docetaxel—skin cancer	0.000399	0.000939	CcSEcCtD
Etonogestrel—Malnutrition—Docetaxel—skin cancer	0.000399	0.000939	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—skin cancer	0.000399	0.000938	CcSEcCtD
Etonogestrel—Dyspepsia—Fluorouracil—skin cancer	0.000398	0.000934	CcSEcCtD
Etonogestrel—Decreased appetite—Fluorouracil—skin cancer	0.000393	0.000923	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00039	0.000916	CcSEcCtD
Etonogestrel—Urticaria—Temozolomide—skin cancer	0.000389	0.000915	CcSEcCtD
Etonogestrel—Asthenia—Dactinomycin—skin cancer	0.000389	0.000914	CcSEcCtD
Etonogestrel—Abdominal pain—Temozolomide—skin cancer	0.000388	0.000911	CcSEcCtD
Etonogestrel—Body temperature increased—Temozolomide—skin cancer	0.000388	0.000911	CcSEcCtD
Etonogestrel—Back pain—Docetaxel—skin cancer	0.000386	0.000908	CcSEcCtD
Etonogestrel—Pain—Fluorouracil—skin cancer	0.000386	0.000907	CcSEcCtD
Etonogestrel—Muscle spasms—Docetaxel—skin cancer	0.000384	0.000902	CcSEcCtD
Etonogestrel—Feeling abnormal—Fluorouracil—skin cancer	0.000372	0.000875	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—skin cancer	0.000371	0.000871	CcSEcCtD
Etonogestrel—Vomiting—Bleomycin—skin cancer	0.00037	0.000868	CcSEcCtD
Etonogestrel—Rash—Bleomycin—skin cancer	0.000366	0.000861	CcSEcCtD
Etonogestrel—Dermatitis—Bleomycin—skin cancer	0.000366	0.00086	CcSEcCtD
Etonogestrel—Hypersensitivity—Temozolomide—skin cancer	0.000361	0.000849	CcSEcCtD
Etonogestrel—Urticaria—Fluorouracil—skin cancer	0.000359	0.000843	CcSEcCtD
Etonogestrel—Body temperature increased—Fluorouracil—skin cancer	0.000357	0.000839	CcSEcCtD
Etonogestrel—Asthenia—Temozolomide—skin cancer	0.000352	0.000826	CcSEcCtD
Etonogestrel—Cough—Docetaxel—skin cancer	0.000349	0.000819	CcSEcCtD
Etonogestrel—Pruritus—Temozolomide—skin cancer	0.000347	0.000815	CcSEcCtD
Etonogestrel—Convulsion—Docetaxel—skin cancer	0.000346	0.000813	CcSEcCtD
Etonogestrel—Nausea—Bleomycin—skin cancer	0.000345	0.000811	CcSEcCtD
Etonogestrel—Hypertension—Docetaxel—skin cancer	0.000345	0.00081	CcSEcCtD
Etonogestrel—Vomiting—Dactinomycin—skin cancer	0.000345	0.00081	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—skin cancer	0.000342	0.000803	CcSEcCtD
Etonogestrel—Myalgia—Docetaxel—skin cancer	0.00034	0.000799	CcSEcCtD
Etonogestrel—Arthralgia—Docetaxel—skin cancer	0.00034	0.000799	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000338	0.000794	CcSEcCtD
Etonogestrel—Diarrhoea—Temozolomide—skin cancer	0.000335	0.000788	CcSEcCtD
Etonogestrel—Hypersensitivity—Fluorouracil—skin cancer	0.000333	0.000782	CcSEcCtD
Etonogestrel—Anaphylactic shock—Docetaxel—skin cancer	0.000326	0.000766	CcSEcCtD
Etonogestrel—Oedema—Docetaxel—skin cancer	0.000326	0.000766	CcSEcCtD
Etonogestrel—Dizziness—Temozolomide—skin cancer	0.000324	0.000762	CcSEcCtD
Etonogestrel—Infection—Docetaxel—skin cancer	0.000324	0.000761	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—skin cancer	0.000322	0.000756	CcSEcCtD
Etonogestrel—Nervous system disorder—Docetaxel—skin cancer	0.00032	0.000751	CcSEcCtD
Etonogestrel—Pruritus—Fluorouracil—skin cancer	0.00032	0.000751	CcSEcCtD
Etonogestrel—Skin disorder—Docetaxel—skin cancer	0.000317	0.000744	CcSEcCtD
Etonogestrel—Vomiting—Temozolomide—skin cancer	0.000312	0.000732	CcSEcCtD
Etonogestrel—Anorexia—Docetaxel—skin cancer	0.000311	0.00073	CcSEcCtD
Etonogestrel—Rash—Temozolomide—skin cancer	0.000309	0.000726	CcSEcCtD
Etonogestrel—Diarrhoea—Fluorouracil—skin cancer	0.000309	0.000726	CcSEcCtD
Etonogestrel—Dermatitis—Temozolomide—skin cancer	0.000309	0.000726	CcSEcCtD
Etonogestrel—Headache—Temozolomide—skin cancer	0.000307	0.000722	CcSEcCtD
Etonogestrel—Dizziness—Fluorouracil—skin cancer	0.000299	0.000702	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000297	0.000698	CcSEcCtD
Etonogestrel—Insomnia—Docetaxel—skin cancer	0.000295	0.000693	CcSEcCtD
Etonogestrel—Paraesthesia—Docetaxel—skin cancer	0.000293	0.000688	CcSEcCtD
Etonogestrel—Nausea—Temozolomide—skin cancer	0.000291	0.000684	CcSEcCtD
Etonogestrel—Somnolence—Docetaxel—skin cancer	0.00029	0.000681	CcSEcCtD
Etonogestrel—Vomiting—Fluorouracil—skin cancer	0.000287	0.000675	CcSEcCtD
Etonogestrel—Dyspepsia—Docetaxel—skin cancer	0.000287	0.000674	CcSEcCtD
Etonogestrel—Rash—Fluorouracil—skin cancer	0.000285	0.000669	CcSEcCtD
Etonogestrel—Dermatitis—Fluorouracil—skin cancer	0.000285	0.000669	CcSEcCtD
Etonogestrel—Decreased appetite—Docetaxel—skin cancer	0.000283	0.000666	CcSEcCtD
Etonogestrel—Headache—Fluorouracil—skin cancer	0.000283	0.000665	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Docetaxel—skin cancer	0.000281	0.000661	CcSEcCtD
Etonogestrel—Fatigue—Docetaxel—skin cancer	0.000281	0.00066	CcSEcCtD
Etonogestrel—Pain—Docetaxel—skin cancer	0.000279	0.000655	CcSEcCtD
Etonogestrel—Constipation—Docetaxel—skin cancer	0.000279	0.000655	CcSEcCtD
Etonogestrel—Feeling abnormal—Docetaxel—skin cancer	0.000269	0.000631	CcSEcCtD
Etonogestrel—Nausea—Fluorouracil—skin cancer	0.000268	0.00063	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Docetaxel—skin cancer	0.000267	0.000626	CcSEcCtD
Etonogestrel—Abdominal pain—Docetaxel—skin cancer	0.000258	0.000605	CcSEcCtD
Etonogestrel—Body temperature increased—Docetaxel—skin cancer	0.000258	0.000605	CcSEcCtD
Etonogestrel—Hypersensitivity—Docetaxel—skin cancer	0.00024	0.000564	CcSEcCtD
Etonogestrel—Asthenia—Docetaxel—skin cancer	0.000234	0.00055	CcSEcCtD
Etonogestrel—Pruritus—Docetaxel—skin cancer	0.000231	0.000542	CcSEcCtD
Etonogestrel—Diarrhoea—Docetaxel—skin cancer	0.000223	0.000524	CcSEcCtD
Etonogestrel—Dizziness—Docetaxel—skin cancer	0.000216	0.000507	CcSEcCtD
Etonogestrel—Vomiting—Docetaxel—skin cancer	0.000207	0.000487	CcSEcCtD
Etonogestrel—Rash—Docetaxel—skin cancer	0.000206	0.000483	CcSEcCtD
Etonogestrel—Dermatitis—Docetaxel—skin cancer	0.000205	0.000482	CcSEcCtD
Etonogestrel—Headache—Docetaxel—skin cancer	0.000204	0.00048	CcSEcCtD
Etonogestrel—Nausea—Docetaxel—skin cancer	0.000194	0.000455	CcSEcCtD
